125 related articles for article (PubMed ID: 38604730)
1. Comparison of Human Long-Term Liver Models for Clearance Prediction of Slowly Metabolized Compounds.
Preiss LC; Georgi K; Lauschke VM; Petersson C
Drug Metab Dispos; 2024 May; 52(6):539-547. PubMed ID: 38604730
[TBL] [Abstract][Full Text] [Related]
2. Multi-Well Array Culture of Primary Human Hepatocyte Spheroids for Clearance Extrapolation of Slowly Metabolized Compounds.
Preiss LC; Lauschke VM; Georgi K; Petersson C
AAPS J; 2022 Mar; 24(2):41. PubMed ID: 35277751
[TBL] [Abstract][Full Text] [Related]
3. Determination of Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds: Comparison of a Primary Hepatocyte/Stromal Cell Co-culture with Plated Primary Hepatocytes and HepaRG.
Bonn B; Svanberg P; Janefeldt A; Hultman Ia; Grime K
Drug Metab Dispos; 2016 Apr; 44(4):527-33. PubMed ID: 26851239
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling.
Kratochwil NA; Meille C; Fowler S; Klammers F; Ekiciler A; Molitor B; Simon S; Walter I; McGinnis C; Walther J; Leonard B; Triyatni M; Javanbakht H; Funk C; Schuler F; Lavé T; Parrott NJ
AAPS J; 2017 Mar; 19(2):534-550. PubMed ID: 28050713
[TBL] [Abstract][Full Text] [Related]
5. Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac.
Chan TS; Yu H; Moore A; Khetani SR; Tweedie D
Drug Metab Dispos; 2013 Dec; 41(12):2024-32. PubMed ID: 23959596
[TBL] [Abstract][Full Text] [Related]
6. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.
Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P
J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447
[TBL] [Abstract][Full Text] [Related]
7. Micropatterned Co-Cultures of Human Hepatocytes and Stromal Cells for the Assessment of Drug Clearance and Drug-Drug Interactions.
Lin C; Khetani SR
Curr Protoc Toxicol; 2017 May; 72():14.17.1-14.17.23. PubMed ID: 28463419
[TBL] [Abstract][Full Text] [Related]
8. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
[TBL] [Abstract][Full Text] [Related]
9. Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists.
Hutzler JM; Ring BJ; Anderson SR
Drug Metab Dispos; 2015 Dec; 43(12):1917-28. PubMed ID: 26363026
[TBL] [Abstract][Full Text] [Related]
10. Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450.
Smith S; Lyman M; Ma B; Tweedie D; Menzel K
Drug Metab Dispos; 2021 Nov; 49(11):995-1002. PubMed ID: 34407991
[TBL] [Abstract][Full Text] [Related]
11. Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac.
Chan TS; Yu H; Moore A; Khetani SR; Tweedie D
Drug Metab Dispos; 2019 Jan; 47(1):58-66. PubMed ID: 30552098
[TBL] [Abstract][Full Text] [Related]
12. In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes.
Docci L; Klammers F; Ekiciler A; Molitor B; Umehara K; Walter I; Krähenbühl S; Parrott N; Fowler S
AAPS J; 2020 Oct; 22(6):131. PubMed ID: 33051808
[TBL] [Abstract][Full Text] [Related]
13. Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction.
Umehara K; Cantrill C; Wittwer MB; Di Lenarda E; Klammers F; Ekiciler A; Parrott N; Fowler S; Ullah M
Drug Metab Dispos; 2020 Oct; 48(10):849-860. PubMed ID: 32739889
[TBL] [Abstract][Full Text] [Related]
14. Simplifying the Execution of HepatoPac MetID Experiments: Metabolite Profile and Intrinsic Clearance Comparisons.
Ballard TE; Kratochwil N; Cox LM; Moen MA; Klammers F; Ekiciler A; Goetschi A; Walter I
Drug Metab Dispos; 2020 Sep; 48(9):804-810. PubMed ID: 32623369
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes.
Lin C; Shi J; Moore A; Khetani SR
Drug Metab Dispos; 2016 Jan; 44(1):127-36. PubMed ID: 26452722
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and optimization of a microcavity plate-based human hepatocyte spheroid model for predicting clearance of slowly metabolized drug candidates.
Kukla DA; Belair DG; Stresser DM
Drug Metab Dispos; 2024 May; ():. PubMed ID: 38777596
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.
Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; Houdt JV; Lähteenmäki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
Toxicol Sci; 2018 Apr; 162(2):655-666. PubMed ID: 29329425
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity Correction.
Ma B; Eisenhandler R; Kuo Y; Rearden P; Li Y; Manley PJ; Smith S; Menzel K
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):319-326. PubMed ID: 27101423
[TBL] [Abstract][Full Text] [Related]
20. Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties.
Bowman CM; Benet LZ
Pharm Res; 2019 May; 36(8):113. PubMed ID: 31152241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
